FI88872C - Foerfarande foer framstaellning av sferoider, som aostadkommer laongvarig foerdroejd frigoering av en som kalciumkanalblockerare anvaend dihydropyridin - Google Patents

Foerfarande foer framstaellning av sferoider, som aostadkommer laongvarig foerdroejd frigoering av en som kalciumkanalblockerare anvaend dihydropyridin

Info

Publication number
FI88872C
FI88872C FI870380A FI870380A FI88872C FI 88872 C FI88872 C FI 88872C FI 870380 A FI870380 A FI 870380A FI 870380 A FI870380 A FI 870380A FI 88872 C FI88872 C FI 88872C
Authority
FI
Finland
Prior art keywords
dihydropyride
spheroids
preparation
calcium channel
delayed release
Prior art date
Application number
FI870380A
Other languages
English (en)
Swedish (sv)
Other versions
FI870380A (fi
FI870380A0 (fi
FI88872B (fi
Inventor
Calum Brechin Macfarlane
Alastair Brereton Selkirk
Michael John Dey
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI870380A0 publication Critical patent/FI870380A0/fi
Publication of FI870380A publication Critical patent/FI870380A/fi
Publication of FI88872B publication Critical patent/FI88872B/fi
Application granted granted Critical
Publication of FI88872C publication Critical patent/FI88872C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI870380A 1986-01-30 1987-01-29 Foerfarande foer framstaellning av sferoider, som aostadkommer laongvarig foerdroejd frigoering av en som kalciumkanalblockerare anvaend dihydropyridin FI88872C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82389686A 1986-01-30 1986-01-30
US82389686 1986-01-30
US94087886A 1986-12-10 1986-12-10
US94087886 1986-12-10

Publications (4)

Publication Number Publication Date
FI870380A0 FI870380A0 (fi) 1987-01-29
FI870380A FI870380A (fi) 1987-07-31
FI88872B FI88872B (fi) 1993-04-15
FI88872C true FI88872C (fi) 1993-07-26

Family

ID=27124769

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870380A FI88872C (fi) 1986-01-30 1987-01-29 Foerfarande foer framstaellning av sferoider, som aostadkommer laongvarig foerdroejd frigoering av en som kalciumkanalblockerare anvaend dihydropyridin

Country Status (18)

Country Link
EP (1) EP0231026B1 (fi)
JP (1) JP2524990B2 (fi)
KR (1) KR900005009B1 (fi)
AU (1) AU604672B2 (fi)
CA (1) CA1285227C (fi)
DE (1) DE3782439T2 (fi)
DK (1) DK175216B1 (fi)
ES (1) ES2052500T3 (fi)
FI (1) FI88872C (fi)
GR (1) GR3006148T3 (fi)
HU (1) HU196709B (fi)
IE (1) IE61879B1 (fi)
IL (2) IL81419A0 (fi)
IT (1) IT1206876B (fi)
NO (1) NO174325C (fi)
NZ (1) NZ219090A (fi)
PH (1) PH26366A (fi)
PT (1) PT84213B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
GB2209669B (en) * 1987-09-11 1992-02-12 Squibb & Sons Inc Pharmaceutical composition containing high drug load and method for preparing same
JP2528706B2 (ja) * 1988-05-30 1996-08-28 ゼリア新薬工業株式会社 ジヒドロピリジン化合物の製剤組成物
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
JPH0729926B2 (ja) * 1989-07-25 1995-04-05 大塚製薬株式会社 易吸収性製剤用組成物
CA2126441C (en) * 1991-12-30 1999-12-21 David F. Erkoboni Microcrystalline cellulose spheronization composition
EP0557064B1 (en) * 1992-02-20 1997-06-11 Euroceltique S.A. Modified release formulation
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
TW474824B (en) * 1996-09-13 2002-02-01 Basf Ag The production of solid pharmaceutical forms
US6479496B1 (en) * 1998-09-10 2002-11-12 Cv Therapeutics, Inc. Methods for treating angina with ranolazine
US6303607B1 (en) * 1998-09-10 2001-10-16 Cv Therapeutics, Inc. Method for administering a sustained release ranolanolazine formulation
EP1970052A2 (en) 1999-02-09 2008-09-17 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
AU2005320547B2 (en) 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation

Also Published As

Publication number Publication date
HUT42950A (en) 1987-09-28
NZ219090A (en) 1990-04-26
ES2052500T3 (es) 1994-07-16
KR900005009B1 (ko) 1990-07-16
EP0231026A1 (en) 1987-08-05
HU196709B (en) 1989-01-30
DE3782439T2 (de) 1993-05-19
IL81419A (en) 1991-07-18
IT8767057A0 (it) 1987-01-29
AU604672B2 (en) 1991-01-03
KR870007121A (ko) 1987-08-17
CA1285227C (en) 1991-06-25
NO870368L (no) 1987-07-31
FI870380A (fi) 1987-07-31
NO870368D0 (no) 1987-01-29
IE870229L (en) 1987-07-30
NO174325B (no) 1994-01-10
FI870380A0 (fi) 1987-01-29
DK47787A (da) 1987-07-31
AU6810287A (en) 1987-08-06
FI88872B (fi) 1993-04-15
GR3006148T3 (fi) 1993-06-21
DE3782439D1 (de) 1992-12-10
JPS62252732A (ja) 1987-11-04
EP0231026B1 (en) 1992-11-04
NO174325C (no) 1994-04-20
IL81419A0 (en) 1987-08-31
DK47787D0 (da) 1987-01-29
IE61879B1 (en) 1994-11-30
PT84213B (pt) 1989-03-30
PT84213A (en) 1987-02-01
IT1206876B (it) 1989-05-11
DK175216B1 (da) 2004-07-12
PH26366A (en) 1992-06-01
JP2524990B2 (ja) 1996-08-14

Similar Documents

Publication Publication Date Title
FI88872C (fi) Foerfarande foer framstaellning av sferoider, som aostadkommer laongvarig foerdroejd frigoering av en som kalciumkanalblockerare anvaend dihydropyridin
FI103050B1 (fi) Menetelmä N,O-sulfatoituja heparosaaneja sisältävän koostumuksen valmistamiseksi
DK163431C (da) Analogifremgangsmaade til fremstilling af 4-phenyl-1,3-dioxan-cis-5-ylalken- eller alkansyrederivater
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
DK89783D0 (da) Fremgangsmade til fremstilling af 3-keto-delta4,9-19-nor-steroidderivater
DK170287A (da) Fremgangsmaade til fremstilling af findelte, pulverformede karotinoidpraeparater
IL72565A (en) Fast release pharmaceutical composition containing isopropyl 6-cyano-5-methoxycarbonyl-2-methyl-4-(3-nitrophenyl)-1,4-dihydro-pyridine-3-carboxylate-and process for the preparation thereof
AU1705183A (en) Fremgangsmade til fremstilling af et borstehoved, borstehovedog anvendelse heraf til tandbehandling
NO913780D0 (no) Forbedret fremgangsmaate for fremstilling av masse.
FI830048L (fi) Anvaendning av stabiliserade, pelarformade leror i skikt som katalysatorer i reaktioner som katalyseras av protoner
DK50885D0 (da) 2-cyan-benzimidazolderivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne forbindelser som fungicider
NL960005I2 (nl) Optisch zuivere verbinding, en werkwijze voor de bereiding daarvan.
DK593883A (da) Substituerede phenylsulfonyloxybenzimidazolcarbaminater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
FI882099A0 (fi) Foerfarande foer bedoevning av slaktdjur, som andas med lungor.
FI884720A0 (fi) Kompositioner foer anvaendning som kontrastmedel.
NO822259L (no) Fremgangsmaate for fremstilling av granuler inneholdende urea som hovedkomponent
DK325686A (da) Fremgangsmaade til fremstilling af pulverformet, fritflydende tocoferylsuccinat
AR230283A1 (es) Un procedimiento para la preparacion de un derivado de 4a,9b-trans-hexahidro-ih-piridoindol enantiomerico(+)o racemico(=)
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
NO822260L (no) Fremgangsmaate for fremstilling av granuler inneholdende urea som hovedkomponent
MX7196E (es) Procedimiento microbiologico para la preparacion de 1-carvona,a partir de 1-alfa-pineno o 1-beta-pineno
DK159139C (da) Fremgangsmaade til fremstilling af flade emner, saasom luvforsynede maatter
FI872363A (fi) Bakteriociner och kompositioner, som innehaoller dessa, foer detektion och behandling av virusinfektioner.
NO822534L (no) Oxotienobenzooksepiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
DK84987A (da) Kontinuerlig fremgangsmaade til fremstilling af o,o-di-la-vere-alkylchlorthiophosphat

Legal Events

Date Code Title Description
BB Publication of examined application
FD Application lapsed
FG Patent granted

Owner name: SYNTEX (U.S.A.) INC.

MA Patent expired